phenotype

ROS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ROS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

4444Connections
24Hypotheses
30Analyses
50Outgoing
50Incoming

Summary

ROS is a phenotype associated with neurodegeneration research. Key relationships include: activates, interacts with, regulates. Associated with AD, ALI, ALS. Connected to 1918 entities in the SciDEX knowledge graph.

View on Wiki →

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Reactive Oxygen Species (ROS)

entity · 600 words

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Corticobasal Syndrome (CBS)

disease · 11374 words

Parkinson's Disease

disease · 8807 words

Pathway Diagram

graph TD
    subgraph Signaling["Signaling"]
        ROS["ROS"] -->|"activates"| NRF2["NRF2"]
        ROS["ROS"] -->|"activates"| AUTOPHAGY["AUTOPHAGY"]
        ROS["ROS"] -->|"activates"| FERROPTOSIS_1["FERROPTOSIS"]
        ROS["ROS"] -->|"regulates"| PI3K["PI3K"]
        ROS["ROS"] -->|"activates"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
        ROS["ROS"] -->|"regulates"| GENES["GENES"]
        ROS["ROS"] -->|"activates"| ALZHEIMER["ALZHEIMER"]
        SLC7A11["SLC7A11"] -.->|"inhibits"| ROS["ROS"]
        AUTOPHAGY_2["AUTOPHAGY"] -->|"activates"| ROS["ROS"]
        OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"activates"| ROS["ROS"]
        MITOPHAGY["MITOPHAGY"] -->|"activates"| ROS["ROS"]
        SLC7A11_3["SLC7A11"] -->|"activates"| ROS["ROS"]
        BAX["BAX"] -->|"activates"| ROS["ROS"]
    end
    subgraph Pathology["Pathology"]
        ROS["ROS"] -->|"causes"| DNA["DNA"]
        ROS["ROS"] -->|"causes"| FERROPTOSIS["FERROPTOSIS"]
    end
    style ROS fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style NRF2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style DNA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style FERROPTOSIS fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style FERROPTOSIS_1 fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style PI3K fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style GENES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style SLC7A11 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY_2 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style OXIDATIVE_STRESS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style SLC7A11_3 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style BAX fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (2675)

TargetRelationTypeStr
NRF2activatesgene1.00
AUTOPHAGYactivatespathway1.00
DNAcausesgene1.00
FERROPTOSIScausesphenotype1.00
FERROPTOSISactivatesphenotype1.00

Incoming (1769)

SourceRelationTypeStr
SLC7A11inhibitsgene1.00
AUTOPHAGYactivatesgene1.00
OXIDATIVE STRESSactivatesgene1.00
MITOPHAGYactivatesgene1.00
SLC7A11activatesgene1.00

Targeting Hypotheses (24)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Stathmin-2 Splice Switching to Prevent Axonal Degeneration A 0.664 neurodegeneration RNA binding protein dysregulation across
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen 0.639 neurodegeneration Gene expression changes in aging mouse b
Alpha-gamma cross-frequency coupling enhancement to restore 0.621 Alzheimer's disease Circuit-level neural dynamics in neurode
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.612 neurodegeneration Gene expression changes in aging mouse b
TREM2-ASM Crosstalk in Microglial Lysosomal Senescence 0.612 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener 0.607 neurodegeneration Gene expression changes in aging mouse b
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming 0.589 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.585 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.580 neurodegeneration Gene expression changes in aging mouse b
Heterogeneous astrocyte activation states differentially imp 0.523 Alzheimer's disease SEA-AD Single-Cell Analysis: Cell-Type V
Transglutaminase-2 Cross-Linking Inhibition Strategy 0.488 neurodegeneration Protein aggregation cross-seeding across
Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro 0.488 neurodegeneration What are the mechanisms by which gut mic
APOE Isoform Expression Across Glial Subtypes 0.476 Alzheimer's Disease SEA-AD Gene Expression Profiling — Allen
C1q Inhibition Prevents Synaptic Mitochondrial Dysfunction v 0.455 neurodegeneration Why does PRKN-mediated mitophagy, typica
Cross-Cell Type Synaptic Rescue via Tripartite Synapse Resto 0.454 neurodegeneration Cell type vulnerability in Alzheimer's D
Cross-Seeding Prevention Strategy 0.451 neurodegeneration RNA binding protein dysregulation across
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration 0.448 neurodegeneration Epigenetic reprogramming in aging neuron
Cardiovascular-Neuroinflammation Crosstalk Interruption 0.437 Alzheimer's disease Neuroinflammation and microglial priming
Selective OGA Inhibition as 'Tau Stabilization' Strategy Wit 0.433 neurodegeneration Which tau PTMs are both disease-specific
HSP70 Co-chaperone DNAJB6 Universal Cross-Seeding Inhibitor 0.420 neurodegeneration Protein aggregation cross-seeding across
Low Complexity Domain Cross-Linking Inhibition 0.415 neurodegeneration TDP-43 phase separation therapeutics for
Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption 0.384 neurodegeneration Protein aggregation cross-seeding across
RNA-Binding Competition Therapy for TDP-43 Cross-Seeding 0.374 neurodegeneration Protein aggregation cross-seeding across
Sensory-Motor Circuit Cross-Modal Compensation 0.312 neuroscience Circuit-level neural dynamics in neurode

Mentioning Analyses (30)

Scientific analyses that reference this entity

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 1 hypotheses Top: 0.650

What are the precise temporal dynamics of astrocyte ketone production decline du

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.645

How does engineered C. butyricum cross the blood-brain barrier to directly bind

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.675

What are the physiological functions of BACE1 beyond APP processing that could c

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.527

What molecular mechanisms explain how apoE promotes cerebral amyloid angiopathy

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.544

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics [PMID:41956336] Huang S, Ou Y, Zhuang W, Huang J, Wang B Biochim Biophys Acta Rev Cance 2026 0
A scalable human-zebrafish xenotransplantation model reveals gastrosome-mediated [PMID:41957412] Villani A, Wittmann J, Wyss T, Mallona I Commun Biol 2026 0
Brain atrophy patterns in anti-IgLON5 disease. [PMID:40650880] Yogeshwar SM, Bartels F, Grüter T, Muñiz Brain 2026 0
Potential diagnostic markers in Alzheimer's disease: current perspectives and fu [PMID:40911035] Zheng M, Wang S, Jia J Neurodegener Dis Manag 2026 0
Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyel [PMID:40988129] Furlan R, Schaedelin S, Frederiksen JL, Brain 2026 0
Kidney Function, Alzheimer Disease Blood Biomarkers, and Dementia Risk in Commun [PMID:41337685] Gasparini F, Valletta M, Vetrano DL, Ber Neurology 2026 0
The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and [PMID:41527736] Abedin MJ, Kastanenka KV J Alzheimers Dis 2026 0
Biomarker-integrated prognostic stagings for Alzheimer's Disease. [PMID:41622252] Shin D, Lee S, Kim JP, Jang H, Yun J et Nat Commun 2026 0
Prognostic Value of Plasma NfL and GFAP for Conversion to Alzheimer's Disease an [PMID:41703957] Özkurt Ç, Kelicen-Uğur P Biomarkers 2026 0
From scaffold to effector: reframing GFAP in neurodegeneration. [PMID:41775321] Lu YH, Zhu XP, Li S, Zhang FN, Cai CB et J Adv Res 2026 0
Translating neurofilament light chain testing into clinical practice: a multidis [PMID:41831326] Furlan R, Di Sapio A, Ferraro D, Rossi E Clin Chem Lab Med 2026 0
Role of astrocyte biomarker GFAP in early diagnosis and prognosis assessment of [PMID:41850459] Li S, Wei S, Wang L, Yu T, Wang H et al. Int J Biol Macromol 2026 0
Biocompatible Lubricant-Coated Flexible Neural Probes with Enhanced Long-Term Re [PMID:41860566] Lee H, Lee S, Hwang KS, Kim G, Hong Y et ACS Appl Bio Mater 2026 0
Ythdf2/Setd1b regulatory axis is essential for cerebellar development through re [PMID:41933071] Ren X, Jiang J, Hu X, Zhang M, Li J et a Mol Psychiatry 2026 0
Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's dise [PMID:41936348] Shimasaki R, Kurihara M, Bannai T, Hatan J Prev Alzheimers Dis 2026 0
Etomidate relieves oxaliplatin-induced neuropathic pain by regulating AMPK/Nrf2/ [PMID:41936904] Chen K, Lin Y, Han X, Zhao L, Wang J et Mol Cell Endocrinol 2026 0
A Bayesian classification model for differential diagnosis of Alzheimer's diseas [PMID:41940846] Costa T, Liloia D, Premi E, Ashton N, Ze J Alzheimers Dis 2026 0
Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteo [PMID:41943055] Di Caro V, Cho E, Thiel J, Lizama BN, Ko Alzheimer's research & therapy 2026 0
Associations between air pollution and markers of neuroinflammation, synaptic dy [PMID:41944915] Kimura K, Driscoll I, Cook N, Shahzad S, Neurotoxicity research 2026 0
The role of brain MRI in autoimmune encephalitis. [PMID:41947644] Hartung TJ, Kuchling J, Finke C Curr Opin Neurol 2026 0